04-05-2018 07:35 CET Three-month interim report (Q1) 2018
20-03-2018 16:19 CET Grant of share options and performance shares to members of the Board of Management and key employees
16-03-2018 10:54 CET Articles of Association
12-03-2018 17:22 CET Annual General Meeting in ALK-Abelló A/S held on 12 March 2018
02-03-2018 16:49 CET Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
16-02-2018 07:00 CET ALK’s partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan
13-02-2018 13:55 CET Annual General Meeting in ALK-Abelló A/S on 12 March 2018
06-02-2018 07:30 CET ALK releases its annual report 2017
30-01-2018 15:54 CET Release date of annual report 2017 and audio cast
20-12-2017 11:06 CET ALK – Financial calendar for the 2018 financial year
11-12-2017 16:29 CET Reporting of transactions with ALK-Abelló A/S' B-shares and associated securities by person closely associated with person discharging managerial responsibly
11-12-2017 10:51 CET REGISTRATION OF CAPITAL INCREASE OF DKK 92,076 AA SHARES AND DKK 920,760 B SHARES BY THE ISSUE OF NEW SHARES COMPLETED
07-12-2017 13:51 CET Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
07-12-2017 08:01 CET PRICING AND FURTHER DETAILS ON THE OFFERING OF NEW SHARES IN ALK-ABELLÓ A/S
06-12-2017 17:03 CET ALK-ABELLÓ A/S TO ISSUE UP TO 92,076 AA SHARES AND UP TO 920,760 B SHARES IN A PRIVATE PLACEMENT
04-12-2017 07:30 CET ALK launches ambitious, transformational growth strategy
30-11-2017 12:27 CET ALK secures pricing and reimbursement for ACARIZAX® in France
29-11-2017 08:26 CET Management change at ALK
28-11-2017 12:50 CET ALK to launch updated corporate strategy on 4 December
10-11-2017 07:30 CET Nine-month interim report (Q3) 2017